This disease is historically called refractory anemia with ringed sideroblasts (MDS-RS) and over 75% of patients with MDS-RS have SF3B1 mutations (Papaemmanuil E. et al., 2011). This evidence concerns the gene SF3B1 and X-linked retinoschisis.